News Daily News AI Has Great Potential in CV Pharmacotherapy, but Much Work Lies Ahead: Review Though most models aren’t ready for prime time, AI is expected to have a “tremendous” impact on practice in the coming years. Todd Neale July 24, 2025
Presentation ACC 2025 FAIR-HF2 Trial: Intravenous iron in patients with systolic heart failure and iron deficiency to improve morbidity & mortality Presenter: Stefan D. Anker March 30, 2025
Presentation ACC 2025 The MIGHTy-Heart Randomized Clinical Trial Presenter: Ruth Masterson Creber March 30, 2025
Presentation ACC 2025 Liberal Fluid Intake versus Fluid Restriction in Chronic Heart Failure: The FRESH-UP Study Presenter: Roland R. Van Kimmenade March 30, 2025
Presentation ACC 2025 Dapagliflozin after Transcatheter Aortic Valve Implantation Presenter: Sergio Raposeiras-Roubin March 29, 2025
Presentation THT 2025 Voice of the Heart: SQ ICM for Heart Failure Using ECG and Heart Sounds as Biomarkers Presenter: Jaeson Bang February 13, 2025
News Daily News Key Subgroups of HF Patients Missing Out on SGLT2 Inhibitors: Registry Data By L.A. McKeown July 24, 2025
News Daily News AI Has Great Potential in CV Pharmacotherapy, but Much Work Lies Ahead: Review By Todd Neale July 24, 2025
News Daily News Some Ups, Some Downs in Proposed CMS Reimbursement for 2026, Cardiologists Say By L.A. McKeown July 22, 2025
News Daily News FDA Approves Finerenone for HF Patients With Mildly Reduced or Preserved EF By Caitlin E. Cox July 14, 2025